menu
  • For
    Professionals
  • For
    Patients
  •  
    中文版
  • About SCAN
  • Purpose
  • Workgroups
  • Methodology
  1. Home
  2. Guidelines

SCAN by topic

Lung Cancer (Systemic Therapy)

  • Summary Recommendations

  • Pathological reporting and molecular subtyping

  • First-line treatment options for epidermal growth factor receptor (EGFR) sensitising mutation-positive advanced Non- Small Cell Lung Cancer (NSCLC)

  • First-line treatment options for advanced Non- Small Cell Lung Cancer (NSCLC) harbouring anaplastic lymphoma kinase (ALK) gene rearrangement

  • First-line chemotherapeutic options for advanced Non- Small Cell Lung Cancer (NSCLC) with no driver mutation

  • Role of maintenance chemotherapy

  • Second-line chemotherapeutic options

  • Subsequent lines of treatment options

  • References

All categories

  • Bladder Cancer
  • Breast Cancer (Trastuzumab Use)
  • Breast Cancer (Bisphosphonate Use)
  • Colorectal Cancer (Adjuvant)
  • Colorectal Cancer (Palliative)
  • Endometrial Cancer
  • Glioma
  • Hereditary Cancer
  • Lung Cancer (Adjuvant Chemotherapy)
  • Lung Cancer (Systemic Therapy)
  • Ovarian Cancer
  • Pancreatic Cancer
  • Prostate Cancer
  • Renal Cell Carcinoma
  • Sarcoma (Extremity STS and Osteosarcoma)
  • Sarcoma (Retroperitoneal STS)

Guidelines endorsed by the Chapter of Medical Oncologists, Academy of Medicine and the Singapore Society of Oncology.

Full texts are copyrighted © 2015 by Annals, Academy of Medicine. Reproduced here by permission. All rights reserved.

  • Terms and Conditions
  • Contact Us